Objective: The goal of this study is to investigate the effects of sorafenib on tumor growth,
recurrence and metastasis after curative resection of liver cancer. Research methods …

Objective: To investigate the inhibitory effect of AKR1B10 inhibitor combined with sorafenib
on hepatocellular carcinoma (HCC) xenograft growth. Methods: HepG2 xenograft model …

Sorafenib treatment on Chinese patients with advanced hepato... : Medicine Sorafenib
treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic …

Background: Sorafenib has recently been shown to reduce tumour growth in
hepatoblastoma (HB) xenografts. The effect of a combined administration with cytostatic …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. Sorafenib, a molecular-targeted drug, is a multi-target oral anti-neoplastic drug …

Abstract Background and Objective: Sorafenib is recommended for treating advanced
hepatocellular carcinoma. However, it is frequently discontinued because of adverse events …

The multikinase-inhibition action of sorafenib provides strong rationales for its combination
use with radiotherapy. We investigated the in vitro and in vivo effect of sorafenib combined …

Purpose: Sorafenib has proved survival benefit for patients with advanced hepatocellular
carcinoma (HCC). This study explored whether the efficacy of sorafenib can be improved by …

Purpose Sorafenib is a multikinase inhibitor used for treatment of advanced hepatocellular
carcinoma. Sorafenib resistance may be related to Src-induced cell migration and …

Background. Sorafenib is a multikinase inhibitor currently used in the treatment of
hepatocellular carcinoma, renal cell carcinoma and thyroid cancer. Objectives. The literature …